Jula Inrig

EVP, Head of R&D & CMO

EVP, Head of R&D & CMO at Travere Therapeutics, Inc., filing insider transactions on 2026-09-15.

Total Purchases

—

0 transactions

Total Sales

$2.8M

4 transactions

Companies Traded

1

4 total filings

Active Since

2026-09-15

Last: 2026-09-15

Companies

Travere Therapeutics, Inc.

Other Reporting Insiders at Travere Therapeutics, Inc.

Transaction History

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-09-15	TVTX	Sale	25.4K	$62.02	$1.6M	119.8K	SEC ↗
2026-09-15	TVTX	Sale	17.3K	$62.62	$1.1M	102.5K	SEC ↗
2026-09-15	TVTX	Sale	1,600	$63.69	$102K

Jula Inrig (Travere Therapeutics, Inc.) Insider Trades | Tormere